Клетка «на диете». Научное открытие о влиянии жиров на мышление, физическую активность и обмен веществ

12. R. Pamplona, “Mitochondrial DNA Damage and Animal Longevity: Insights from Comparative Studies,” Journal of Aging Research, 2011 (2011): DOI: 10.4061/2011/807108.

13. P. Sonksen and J. Sonksen, “Insulin: Understanding Its Action in Health and Disease,” British Journal of Anaesthesia, 85, no. 1 (2000): 69–79, DOI: 10.1093/ bja/85.1.69.

14. M. J. Wargovich and J. E. Cunningham, “Diet, Individual Responsiveness and Cancer Prevention,” The Journal of Nutrition, 133 (July 2003): 2400S-2403S, PMID 12840215.

15. M. V. Chakravarthy and F. W. Booth, “Eating, Exercise, and ‘Thrifty’ Genotypes: Connecting the Dots toward an Evolutionary Understanding of Modern Chronic Diseases,” Journal of Applied Physiology, 96, no. 1 (2004): 3-10, DOI:10.1152/jappl-physiol.00757.2003.

16. V. D. Longo and M. P. Mattson, “Fasting: Molecular Mechanisms and Clinical Applications,” Cell Metabolism, 19, no. 2 (2014):181-92, DOI:10.1016/jc-met.2013.12.008.

Глава 11

1. Body to the Earth’s Surface Electrons,” Journal of Environmental and Public Health, 2012, (2012), DOI: 10.1155/2012/291541.

2. J. L. Oschman, G. Chevalier, and R. Brown, “The Effects of Grounding (Earthing) on Inflammation, the Immune Response, Wound Healing, and Prevention and Treatment of Chronic Inflammatory and Autoimmune Diseases,” Journal of Inflammation Research, 8 (2015): 83–96, DOI: 10.2147/JIR.S69656.

3. D. Z. Kochan et al, “Circadian Disruption and Breast Cancer: An Epigenetic Link?” Oncotarget, 6, no. 19 (2015): 16866-16682. DOI:10.18632/oncotarget.4343.

4. M. Dunbar and R. Melton, “The Lowdown on Light: Good vs. Bad, and Its Connection to AMD,” Review of Optometry, https://www.reviewofoptometry.com/ce/ the-lowdown-on-blue-light-good-vs-bad-and-its-connection-toamd-109744, accessed November 28, 2016.

5. D. Peretti et al, “RBM3 Mediates Structural Plasticity and Protective Effects of Cooling in Neurodegeneration,” Nature, 518, no. 7538 (2015):236-39, DOI: 10.1038/naturel4142.

Приложение А

1. Load Diet in Treatment of Acne Vulgaris in Korean Patients: A Randomized, Controlled Trial.” Acta Dermato Venereologica, 92, no. 3 (May 2012): 241-46, DOI: 10.2340/00015555-1346.

2. L. Knott et al., “Regulation of Osteoarthritis by Omega-3 (n-3) Polyunsaturated Fatty Acids in a Naturally Occurring Model of Disease,” Osteoarthritis Cartilage, 19, no. 9 (September 2011): 1150-57, DOI: 10.1016/j.joca.2011.06.005.

3. L. Cordain et al., “Acne Vulgaris: A Disease of Western Civilization,” Archives of Dermatology, 138, no. 12 (December 2002): 1584-0, DOI: 10.1001/arch-derm.138.12.1584.

4. R. N. Smith et al., “A Low-Glycemic-Load Diet Improves Symptoms in Acne Vulgaris Patients: A Randomized Controlled Trial,” American Journal of Clinical Nutrition, 86, no. 1 (July 2007): 107–115.

5. Kwon et al, “Clinical and Histological Effect of a Low Glycaemic Load Diet in Treatment of Acne Vulgaris in Korean Patients.”

6. S. N. Mahmood and W.P. Bowe, “Diet and Acne Update: Carbohydrates Emerge as the Main Culprit,” Journal of Drugs in Dermatology, 13, no. 4, (April 2014): 428-35.

7. “2015 Alzheimer’s Disease Facts and Figures,” Alzheimer’s Association, https://www. alz.org/facts/downloads/facts_figures_2015.pdf, accessed November 28, 2016.

8. World Health Organization. “Dementia: a Public Health Priority” (Geneva, SUI: World Health Organization, 2012), PMID: 19712582.

9. B. D. James et al., “Contribution of Alzheimer Disease to Mortality in the United States,” Neurology,published online before print March 5, 2014, DOI: 10.1212/ WNL.0000000000000240.

10. V. R. Bitra, D. Rapaka, and A. Akula, “Prediabetes and Alzheimer’s Disease,” Indian Journal of Pharmaceutical Sciences, 77, no. 5 (2015): 511-14.

11. S. M. de la Monte, “Insulin Resistance and Alzheimer’s Disease,” BMB Reports, 42, no. 8 (2009): 475-81.

12. R. O. Roberts et al., “Relative Intake of Macronutrients Impacts Risk of Mild Cognitive Impairment or Dementia,” Journal of Alzheimers Disease, 32, no. 2 (2012), 329-39. DOI: 10.3233/JAD-2012-120862.

13. S. T. Henderson et al., “Study of the Ketogenic Agent AC-1202 in Mild to Moderate Alzheimer’s Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial,” Nutrition & Metabolism, 6 (2009): 31. DOI: 10.1186/1743-7075-6-31, PMID: 19664276.

14. J. Yao and R. D. Brinton, “Targeting Mitochondrial Bioenergetics for Alzheimer’s Prevention and Treatment,” Current Pharmaceutical Design, 17, no. 31, (2011): 3474-79, PMID: 21902662.